Schedule 13D ownership disclosure

INTERCEPT PHARMACEUTICALS IN

Security class unavailable · CUSIP: 45845P108

Event date: 2015-03-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.6400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-15-000231
Form type
SC 13D/A
Filer
INTERCEPT PHARMACEUTICALS, INC.
CIK
CIK 1270073
Filed
Mar 25, 2015
Reporting period
Mar 23, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub